Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totaling 40,960 shares, a decline of 65.5% from the December 15th total of 118,829 shares. Approximately 2.8% of the shares of the company are short sold. Based on an average daily trading volume, of 34,610 shares, the short-interest ratio is currently 1.2 days. Based on an average daily trading volume, of 34,610 shares, the short-interest ratio is currently 1.2 days. Approximately 2.8% of the shares of the company are short sold.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Astrotech in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Astrotech presently has an average rating of “Sell”.
Get Our Latest Stock Analysis on ASTC
Hedge Funds Weigh In On Astrotech
Astrotech Price Performance
NASDAQ ASTC opened at $3.67 on Thursday. Astrotech has a 12 month low of $2.46 and a 12 month high of $8.01. The firm has a market capitalization of $6.46 million, a PE ratio of -0.43 and a beta of 0.34. The company’s 50 day simple moving average is $3.50 and its 200 day simple moving average is $4.49.
Astrotech (NASDAQ:ASTC – Get Free Report) last released its earnings results on Thursday, November 13th. The aerospace company reported ($2.07) earnings per share for the quarter. Astrotech had a negative return on equity of 59.71% and a negative net margin of 1,069.89%.The firm had revenue of $0.30 million during the quarter.
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Featured Stories
- Five stocks we like better than Astrotech
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
